Luay Mrad, MD
Interventional Pain Medicine · Parkersburg, WVNPI 1922449115
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,758 of the $7,875 with a category attached, or 60.4%. 13 manufacturers reported payments, led by Stryker at 26.3% of the total.
Across 84 payments — averaging $93.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Relievant Medsystems, Inc.$1K
- Abbott$1K
- Pacira Pharmaceuticals Incorporated$1K
- Medtronic$955
- Saluda Medical Americas, Inc.$444
- plus $565 from 7 others
What the payments were for
- Travel & lodging$4,75860%
- Food & beverage$3,11740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 10 | $2,073 |
| Relievant Medsystems, Inc. | 9 | $1,360 |
| Abbott | 15 | $1,332 |
| Pacira Pharmaceuticals Incorporated | 6 | $1,146 |
| Medtronic | 21 | $955 |
| Saluda Medical Americas, Inc. | 10 | $444 |
| Nevro Corp. | 2 | $143 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| Vertos Medical, Inc. | 4 | $120 |
| Boston Scientific | 2 | $69 |
| Curonix LLC | 1 | $66 |
| MML US, Inc. | 2 | $31 |
| SPR Therapeutics, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$4,634
- mild Device Kit$1,533
- Iovera$1,060
- PROCLAIM$840
- SPINEJACK$430
- CLYDESDALE PTC SPINAL SYSTEM$203
- NURTEC ODT$125
- INTELLIS ADAPTIVESTIM$125
- Omnia$110
- Evoke$105
How this compares
Too few interventional pain medicine providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $385 |
| Methylprednisolone | 37 | $230 |
| Oxycodone Hcl | 33 | $151 |
| Cephalexin | 15 | $74 |
| Meloxicam | 46 | $61 |
| Tramadol Hcl | 11 | $20 |
| Diazepam | 30 | $20 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Parkersburg
- Timothy DeerCharleston$3.4M
- Christopher KimCharleston$108K
- Rudy MalayilHuntington$104K
- Andrew ThymiusBeckley$9K
- Raymond GreaserWheeling$9K
- Stephanie leWeirton$9K
- Corinne Layne StuartBridgeport$8K
- Anuj ShahCharleston$7K
- George van OstenMartinsburg$145
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.